Home/Filings/4/0001209191-15-036657
4//SEC Filing

NUVASIVE INC 4

Accession 0001209191-15-036657

CIK 0001142596operating

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 4:47 PM ET

Size

15.4 KB

Accession

0001209191-15-036657

Insider Transaction Report

Form 4
Period: 2015-04-24
Powers Russell
Exec. VP Sales Int'l Ops
Transactions
  • Tax Payment

    Common Stock

    2015-04-24$43.99/sh1,721$75,70782,953 total
  • Sale

    Common Stock

    2015-04-24$44.07/sh3,888$171,34482,440 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2015-04-24+6,2500 total
    Exercise: $26.62Exp: 2021-01-03Common Stock (6,250 underlying)
  • Exercise/Conversion

    Common Stock

    2015-04-24$26.62/sh+6,250$166,37586,328 total
  • Exercise/Conversion

    Common Stock

    2015-04-24$26.62/sh+2,234$59,46984,674 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy

    2015-04-24+2,2340 total
    Exercise: $26.62Exp: 2012-01-03Common Stock (2,234 underlying)
Footnotes (6)
  • [F1]Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
  • [F2]Sale of shares for payment of the exercise price of the underlying stock options. Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person on March 10, 2015, which is intended to comply with Rule 10b5-1.
  • [F3]Weighted average from 4 transactions with prices ranging from $44.0600 to $44.080. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
  • [F4]Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
  • [F5]The option, representing a right to purchase a total of 10,266 shares, became exercisable as follows: 25% of the shares vested on January 3, 2012; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2015, subject to continued employment through each vesting period.
  • [F6]The option, representing a right to purchase a total of 2,234 shares, became exercisable as follows: 25% of the shares vested on January 3, 2012; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2015, subject to continued employment through each vesting period.

Issuer

NUVASIVE INC

CIK 0001142596

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001142596

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 4:47 PM ET
Size
15.4 KB